Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Apr 2019
Historique:
received: 07 12 2018
revised: 04 02 2019
accepted: 06 02 2019
pubmed: 25 2 2019
medline: 19 6 2020
entrez: 25 2 2019
Statut: ppublish

Résumé

Respiratory complications are relevant in DM1, leading to a significantly increased morbidity and mortality risk in these patients; however, so far only few studies concerning respiratory function have been conducted in DM1 patients. We report a retrospective, multicenter, cross sectional study on a large cohort of DM1 patients widely characterized in the phenotype, to assess prevalence and identify predictors of restrictive respiratory syndrome. 268 DM1 subjects aged >18 years, who had recently performed spirometric tests were included; restrictive syndrome was diagnosed if forced vital capacity (FVC) <80% of predicted. This cut-off was used for statistical univariate and multivariate analysis. 51.9% patients showed a restrictive syndrome, and half of them had indication to non-invasive ventilation (NIV), yet only 50% resulted compliant to NIV. CTG expansion size in leukocytes, clinical muscle severity, most functional parameters of respiratory muscle involvement, presence of cardiac conduction disturbances, pacemaker (PMK), exertion dyspnea, obstructive sleep apnea, and indication and compliance to NIV were all significantly associated with restrictive syndrome at the univariate analysis; in the multivariate model only the first two factors resulted independent predictors. A high prevalence of restrictive syndrome in our DM1 cohort, mainly due to respiratory muscles weakness, was observed and documented; the severity of muscle impairment and the CTG expansion size confirmed to be independent predictors of respiratory restriction. Our data suggest that optimization of respiratory therapeutic management, particularly regarding launching of NIV, might help to reduce the rate of deaths due to respiratory complications in DM1.

Identifiants

pubmed: 30798109
pii: S0022-510X(19)30073-5
doi: 10.1016/j.jns.2019.02.012
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-124

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Salvatore Rossi (S)

Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, 00168 Rome, Italy; Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Giacomo Della Marca (G)

Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, 00168 Rome, Italy; Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Martina Ricci (M)

Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Alessia Perna (A)

Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Tommaso F Nicoletti (TF)

Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Valerio Brunetti (V)

Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Emiliana Meleo (E)

NEuroMuscular Omnicentre (NEMO), Serena Onlus Foundation - Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito 1, 00168 Rome, Italy.

Mariarosaria Calvello (M)

Pneumology Unit, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.

Antonio Petrucci (A)

Center for Neuromuscular and Neurological Rare Diseases S. Camillo Forlanini Hospital, Cir.ne Gianicolense 87, 00152 Rome, Italy.

Giovanni Antonini (G)

Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Elisabetta Bucci (E)

Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Loretta Licchelli (L)

Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Cristina Sancricca (C)

Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, 00168 Rome, Italy; Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy; Unione Italiana Lotta alla Distrofia Muscolare (UILDM) sez. Laziale, via Prospero Santacroce 5, 00167 Rome, Italy.

Roberto Massa (R)

Neuromuscular Diseases Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

Emanuele Rastelli (E)

Neuromuscular Diseases Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

Annalisa Botta (A)

Department of Biomedicine and Prevention, Medical Genetics Section, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

Antonio Di Muzio (A)

Regional Center for Neuromuscular Diseases, Ospedale Clinicizzato SS Annunziata, Via dei Vestini, 66100 Chieti, Italy.

Sonia Romano (S)

Regional Center for Neuromuscular Diseases, Ospedale Clinicizzato SS Annunziata, Via dei Vestini, 66100 Chieti, Italy.

Matteo Garibaldi (M)

Center for Neuromuscular and Neurological Rare Diseases S. Camillo Forlanini Hospital, Cir.ne Gianicolense 87, 00152 Rome, Italy.

Gabriella Silvestri (G)

Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Largo A. Gemelli 8, 00168 Rome, Italy; Institute of Neurology, Catholic University of the Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy. Electronic address: gabriella.silvestri@unicatt.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH